Drugs / S2G6T-2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02842021 Comparator | Sep 2016 → Oct 2017 | tinea pedis | Sol-Gel Technologies, Ltd. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S2G6T-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02842021 ↗ |